Anthony Shen
Pulmonary Disease · Saint Louis, MONPI 1831160761
Payments from drug & device makers
Across 734 payments — averaging $17.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- Boehringer Ingelheim$2K
- AstraZeneca$2K
- Actelion Pharmaceuticals US, Inc.$1K
- Insmed, Inc.$695
- Grifols USA, LLC$583
- plus $4K from 30 others
What the payments were for
- Food & beverage$12,58198%
- Education$2652%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 156 | $2,253 |
| Boehringer Ingelheim | 96 | $2,168 |
| AstraZeneca | 101 | $1,667 |
| Actelion Pharmaceuticals US, Inc. | 72 | $1,392 |
| Insmed, Inc. | 32 | $695 |
| Grifols USA, LLC | 33 | $583 |
| Regeneron Healthcare Solutions, Inc. | 17 | $407 |
| Electromed, Inc. | 42 | $391 |
| Sanofi | 16 | $355 |
| United Therapeutics Corporation | 18 | $338 |
| Bayer | 22 | $327 |
| Jazz Pharmaceuticals Inc. | 11 | $303 |
| E.r. Squibb & Sons, L.L.C. | 16 | $262 |
| Mylan Specialty L.p. | 12 | $247 |
| Philips North America LLC | 9 | $184 |
| Advanced Respiratory, Inc | 10 | $168 |
| Sunovion Pharmaceuticals Inc. | 17 | $157 |
| Pfizer | 8 | $134 |
| Novartis | 4 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $81 |
| Johnson & Johnson | 6 | $71 |
| Amgen | 3 | $64 |
| Gilead | 4 | $58 |
| Merck | 3 | $52 |
| Genentech USA, Inc. | 3 | $51 |
| Circassia Inc. | 3 | $46 |
| Shire North American Group Inc | 3 | $46 |
| Fisher & Paykel Healthcare Inc | 3 | $44 |
| Inogen, Inc. | 1 | $41 |
| Harmony Biosciences LLC | 2 | $33 |
| Cumberland Pharmaceuticals, Inc. | 2 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Pulmonx Corporation | 1 | $15 |
| Apria Healthcare LLC | 1 | $14 |
| Resmed Corp | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,846 in reported general payments places this provider in the 75th percentile of 295 pulmonary disease providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 45 | $35,260 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $9,670 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $956 |
| Montelukast Sodium | 23 | $221 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $2,253 | $44,93060 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 295 pulmonary disease providers in Missouri.
Other pulmonary disease in Saint Louis
- Murali ChakinalaSaint Louis$2.4M
- Joseph OjileSaint Louis$2.1M
- Jeffrey HarrisSaint Louis$1.1M
- Kaharu SuminoSaint Louis$1.1M
- Tonya RussellSaint Louis$1M
- Alexander ChenSaint Louis$951K
- Daniel RosenbluthSaint Louis$903K
- Derek ByersSaint Louis$835K
- Jeffrey AtkinsonSaint Louis$604K
- James KringsSaint Louis$505K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.